Telomir Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Miami, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Telomir Pharmaceuticals, Inc. has filed 134 SEC EDGAR filings since 03 Apr 2023

SEC filing history

Showing 51-75 of 134 matching filings.

Per page
25
Current page
3
3

3 filing

Filing date
10 Jun 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 May 2025
Reporting date
28 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284990

EFFECT filing

Filing date
28 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-284990

UPLOAD filing

Filing date
20 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-41952

10-K filing

Filing date
04 Feb 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
5

5 filing

Filing date
04 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .